Cisiv

Cisiv is a data management company that specializes in real-world late phase research, providing integrated solutions for effective data collection in clinical development across the life sciences sector. Cisiv focuses on delivering a platform tailored for late phase research, enhancing data management for clinical studies. Founded by Ruth Whittaker, the company has successfully secured Series C funding of GBP 2. 100 mn from Parkwalk Advisors as of May 25, 2016, bringing the total amount raised to GBP 2.

100 mn and the current company valuation to GBP 6. 417 mn. The company is headquartered in London, UK. Cisiv offers an integrated platform specifically designed for real-world late phase research, enabling efficient data collection and management in clinical development.

Their system caters to a diverse clientele including research organizations and life science companies worldwide, allowing for streamlined data access and management without reliance on multiple systems. It facilitates engagement with both physicians and patients, ensuring accurate curation of essential data on the effectiveness and safety of medicinal products and medical devices. Their technology provides insights into disease patterns, enhancing decision-making in clinical research across markets in North America, Europe, and Asia. Cisiv's revenue model is grounded in subscription agreements and partnerships with research organizations and life sciences companies.

Clients utilize the platform through tiered support offerings, which include 365-day Tier 1 support and standard business hours Tier 2 support. These agreements typically encompass a variety of services aligned with the platform’s capabilities, aimed at improving operational efficiencies and accelerating data collection processes. While specific pricing plans for products or services are not disclosed, the company emphasizes scalability and adaptability to meet its clients' unique needs, fostering long-term relationships through its comprehensive support structure. Cisiv's recent Series C funding will be pivotal in advancing its product offerings and expanding into new geographic markets.

The company is actively working on enhancing its platform capabilities and plans to launch new features that will further streamline real-world data applications. Future expansions are targeted towards increasing market penetration in North America, Europe, and Asia, with a strategic focus on enhancing its presence by leveraging new technologies and insights. The financial support from the latest funding round is intended to drive these initiatives and strengthen the company’s market position.